The Patent Finder

Aurelium Biopharma Inc.

Also on record
Records under this name other than patents Aurelium Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Aurelium Biopharma Inc.

PatentTitleStatus Expires Confidence
US 7,670,604Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
Lapsed on the fee record
Ended Mar 2, 2014 · From the USPTO record
Lapsed on the fee recordEnded Mar 2, 2014From the USPTO record
US 7,662,580Tissue diagnostics for breast cancer
Lapsed on the fee record
Ended Feb 16, 2014 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2014From the USPTO record
US 7,550,256Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
Lapsed on the fee record
Ended Jun 23, 2013 · From the USPTO record
Lapsed on the fee recordEnded Jun 23, 2013From the USPTO record
US 7,413,851Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
Lapsed on the fee record
Ended Aug 19, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2012From the USPTO record
US 7,358,042Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
Lapsed on the fee record
Ended Apr 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2012From the USPTO record
US 7,226,748HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
Lapsed on the fee record
Ended Jun 5, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2011From the USPTO record
US 4,333,900Process for manufacture of high voltage transformers and the like
Term ended
Term ended no later than Jun 8, 2002 · Low confidence
Term endedTerm ended no later than Jun 8, 2002Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited